Kiora Pharmaceuticals annual capital expenditures (capex)
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Kiora Pharmaceuticals Capital Expenditures (CapEx) Growth & History (KPRX)
Kiora Pharmaceuticals's capital expenditures (capex) was $110,789 for fiscal 2025.
View full Kiora Pharmaceuticals company overviewKiora Pharmaceuticals annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $110,789 | $104,533 | +1670.92% |
| 2024 | 2024-12-31 | $6,256 | $6,256 | — |
| 2023 | 2023-12-31 | $0 | $0 | — |
| 2022 | 2022-12-31 | $0 | −$63,865 | — |
| 2021 | 2021-12-31 | $63,865 | $43,788 | +218.10% |
| 2020 | 2020-12-31 | $20,077 | $20,077 | — |
| 2019 | 2019-12-31 | $0 | −$20,000 | — |
| 2018 | 2018-12-31 | $20,000 | −$16,999 | −45.94% |
| 2017 | 2017-12-31 | $36,999 | $36,999 | — |
| 2016 | 2016-12-31 | $0 | — | — |
Kiora Pharmaceuticals quarterly capital expenditures (capex)
Q1.21
Q2.21
Q3.21
Q4.21
Q3.23
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $23,456 | −$8,739 | −27.14% |
| Q1 2026 | 2026-03-31 | $5,018 | $5,018 | — |
| Q4 2025 | 2025-12-31 | $78,163 | — | — |
| Q3 2025 | 2025-09-30 | $431 | $431 | — |
| Q2 2025 | 2025-06-30 | $32,195 | — | — |
| Q1 2025 | 2025-03-31 | $0 | — | — |
| Q3 2024 | 2024-09-30 | $0 | $0 | — |
| Q3 2023 | 2023-09-30 | $0 | — | — |
| Q4 2021 | 2021-12-31 | $0 | — | — |
| Q3 2021 | 2021-09-30 | $0 | — | — |
| Q2 2021 | 2021-06-30 | $5,746 | — | — |
| Q1 2021 | 2021-03-31 | $58,119 | — | — |
Kiora Pharmaceuticals capital expenditures (capex) trends
Over the last five fiscal years, Kiora Pharmaceuticals's capital expenditures (capex) increased from $20,077 to $110,789, a change of $90,712. The latest reported quarter, Q2 2026, shows $23,456.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Kiora Pharmaceuticals source filings ↗